Pulmonary Complications during Mecamylamine Therapy
作者： Rolf Rokseth , Ole Storstein
DOI: 10.1111/J.0954-6820.1960.TB03511.X
关键词:
摘要:
sci-hub.se 参考文章(9)
JOHN D. MORROW, HENRY A. SCHROEDER, H. MITCHELL PERRY, Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects. Circulation. ,vol. 8, pp. 829- 839 ,(1953) , 10.1161/01.CIR.8.6.829
Robert Austrian, John H. McClement, Attilio D. Renzetti, Kenneth W. Donald, Richard L. Riley, André Cournand, Clinical and physiologic features of some types of pulmonary diseases with impairment of alveolar-capillary diffusion: The syndrome of “alveolar-capillary block” The American Journal of Medicine. ,vol. 11, pp. 667- 685 ,(1951) , 10.1016/0002-9343(51)90019-8
T. Hildeen, A.R. Krogsgaard, BJ. Vimtrup, FATAL PULMONARY CHANGES DURING THE MEDICAL TREATMENT OF MALIGNANT HYPERTENSION The Lancet. ,vol. 272, pp. 830- 832 ,(1958) , 10.1016/S0140-6736(58)90380-5
H.Mitchell Perry, Robert M. O'Neal, Wilbur A. Thomas, Pulmonary disease following chronic chemical ganglionic blockade The American Journal of Medicine. ,vol. 22, pp. 37- 50 ,(1957) , 10.1016/0002-9343(57)90336-4
B. Morrison, Parenteral Hexamethonium in Hypertension BMJ. ,vol. 1, pp. 1291- 1299 ,(1953) , 10.1136/BMJ.1.4823.1291
H.J. Goldsmith, D.W. Beaven, H.P. Lambert, Severe hypertension treated with hexamethonium bromide in retard medium. The Lancet. ,vol. 265, pp. 371- 374 ,(1955) , 10.1016/S0140-6736(55)91269-1
A.C. Corcoran, H.P. Dustan, R.D. Taylor, Irvine H. Page, Management of hypertensive disease The American Journal of Medicine. ,vol. 17, pp. 383- 394 ,(1954) , 10.1016/0002-9343(54)90248-X
I. Doniach, B. Morrison, R. E. Steiner, LUNG CHANGES DURING HEXAMETHONIUM THERAPY FOR HYPERTENSION Heart. ,vol. 16, pp. 101- 108 ,(1954) , 10.1136/HRT.16.1.101
M D O'Brien, Taking a Neurological History Medicine. ,vol. 28, pp. 1- 7 ,(2000) , 10.1383/MEDC.28.6.1.28557